Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Lee

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Nature Reviews. Clinical Oncology|May 14, 2014
Circulating tumour cells-monitoring treatment response in prostate cancerDavid T Miyamoto, Lecia V Sequist, Richard J Lee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancerPhilip J Saylor, Richard J Lee, Matthew R Smith
Biochemical Pharmacology|September 6, 2002
ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1James Hulit, Richard J Lee, Robert G Russell, et al.
Urologic Oncology|October 17, 2018
Prostate cancer in transgender womenMatthew D Ingham, Richard J Lee, Dhara MacDermed, et al.
Journal of the American Chemical Society|February 13, 2003
Total synthesis of the ramoplanin A2 and ramoplanose aglyconWanlong Jiang, Jutta Wanner, Richard J Lee, et al.
Journal of the American Chemical Society|May 9, 2002
Total synthesis of the ramoplanin A2 and ramoplanose aglyconWanlong Jiang, Jutta Wanner, Richard J Lee, et al.
The Oncologist|March 8, 2021
Disparities in Cancer Care and the Asian American PopulationRichard J Lee, Ravi A Madan, Jayoung Kim, et al.
BJU International|April 17, 2026
Alternatives to radical cystectomy: a bladder-sparing approach in appropriately selected patientsJosé I Nolazco, Kevin R Melnick, Richard J Lee, et al.
Cancer Research|April 4, 2002
Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor propertiesDavid J Bearss, Richard J Lee, Dean A Troyer, et al.
The Journal of Urology|April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancerPhilip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Nature Reviews. Clinical Oncology|May 14, 2014
Circulating tumour cells-monitoring treatment response in prostate cancerDavid T Miyamoto, Lecia V Sequist, Richard J Lee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancerPhilip J Saylor, Richard J Lee, Matthew R Smith
Biochemical Pharmacology|September 6, 2002
ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1James Hulit, Richard J Lee, Robert G Russell, et al.
Urologic Oncology|October 17, 2018
Prostate cancer in transgender womenMatthew D Ingham, Richard J Lee, Dhara MacDermed, et al.
Journal of the American Chemical Society|February 13, 2003
Total synthesis of the ramoplanin A2 and ramoplanose aglyconWanlong Jiang, Jutta Wanner, Richard J Lee, et al.
Journal of the American Chemical Society|May 9, 2002
Total synthesis of the ramoplanin A2 and ramoplanose aglyconWanlong Jiang, Jutta Wanner, Richard J Lee, et al.
The Oncologist|March 8, 2021
Disparities in Cancer Care and the Asian American PopulationRichard J Lee, Ravi A Madan, Jayoung Kim, et al.
BJU International|April 17, 2026
Alternatives to radical cystectomy: a bladder-sparing approach in appropriately selected patientsJosé I Nolazco, Kevin R Melnick, Richard J Lee, et al.
Cancer Research|April 4, 2002
Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor propertiesDavid J Bearss, Richard J Lee, Dean A Troyer, et al.
The Journal of Urology|April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancerPhilip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
Pageof 10